Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indinavir/Ritonavir vs Nelfinavir in NNRTI-Experienced HIV Patients
NCT00541463Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2001
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of indinavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Merck & Co. Primary endpoint: Plasma viral RNA levels. Started Jan 2001; status: completed.
02
Drugs
indinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00541463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541463.